Jacques Gardette
Founder bei Bio Jag SAS
Vermögen: 75 Mio $ am 31.10.2023
Profil
Jacques Gardette was the founder of Bio Jag SAS (2006) and BIOCORP Production SA (2004), where he holds the titles of Chairman and Chairman & Chief Executive Officer, respectively.
Mr. Gardette is also the founder of Brenus Pharma SAS.
Currently, Mr. Gardette holds the position of Chairman in Bio V.A.A SAS, Family Immobilier SAS, Jade CE SAS, Brenus Développement SAS, and CFL BIOTECH SAS.
Additionally, he holds the position of Manager in Brenus Menuiseries SARL, Gilet Aluminium SARL, and Realty France 1 SCI.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOCORP PRODUCTION SA
45,30% | 31.12.2022 | 1 998 800 ( 45,30% ) | 75 Mio $ | 31.10.2023 |
Aktive Positionen von Jacques Gardette
| Unternehmen | Position | Beginn |
|---|---|---|
Bio Jag SAS
 Bio Jag SAS Investment ManagersFinance Bio Jag SAS provide investment services. The company was founded in December 11, 2006 and is headquartered in Clermont-Ferrand, France. | Founder | 11.12.2006 |
| Bio V.A.A SAS | Chairman | - |
| Jade CE SAS | Chairman | - |
| Brenus Développement SAS | Chairman | - |
| Family Immobilier SAS | Chairman | - |
CFL BIOTECH SAS
 CFL BIOTECH SAS Miscellaneous Commercial ServicesCommercial Services CFL BIOTECH SAS is a French company that specializes in researching and developing biotechnology. The private company is based in Issoire, France. | Chairman | - |
Brenus Menuiseries SARL
 Brenus Menuiseries SARL Engineering & ConstructionIndustrial Services Brenus Menuiseries SARL engages in painting and glazing works. The private company is based in Villeneuve De Riviere, France. | Corporate Officer/Principal | - |
Gilet Aluminium SARL
 Gilet Aluminium SARL Wholesale DistributorsDistribution Services Gilet Aluminium SARL is a French company that wholesales wood and building materials. The private company is based in Montayral, France. | Corporate Officer/Principal | - |
| Realty France 1 SCI | Corporate Officer/Principal | - |
| ░░░░░░ ░░░░░░ ░░░ | ░░░░░░░ | - |
Ehemalige bekannte Positionen von Jacques Gardette
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Bio Jag SAS
Bio Jag SAS Investment ManagersFinance Bio Jag SAS provide investment services. The company was founded in December 11, 2006 and is headquartered in Clermont-Ferrand, France. | Finance |
| BIOCORP Production SA | |
| Bio V.A.A SAS | |
| Family Immobilier SAS | |
| Jade CE SAS | |
| Brenus Développement SAS | |
Brenus Menuiseries SARL
Brenus Menuiseries SARL Engineering & ConstructionIndustrial Services Brenus Menuiseries SARL engages in painting and glazing works. The private company is based in Villeneuve De Riviere, France. | Industrial Services |
Gilet Aluminium SARL
Gilet Aluminium SARL Wholesale DistributorsDistribution Services Gilet Aluminium SARL is a French company that wholesales wood and building materials. The private company is based in Montayral, France. | Distribution Services |
CFL BIOTECH SAS
CFL BIOTECH SAS Miscellaneous Commercial ServicesCommercial Services CFL BIOTECH SAS is a French company that specializes in researching and developing biotechnology. The private company is based in Issoire, France. | Commercial Services |
| Realty France 1 SCI | |
Brenus Pharma SAS
 Brenus Pharma SAS Miscellaneous Commercial ServicesCommercial Services Brenus Pharma SAS is a French company that has developed an allogeneic platform to generate first in class immune therapy to prevent cancer resistance over treatment. The company is based in Issoire, France. The company's technology, stc10-10, targets mss and msi-h population with a robust and validated preclinical data pack to offer an off-the-shelf technology allowing control of both time and cost of the manufacturing process. Brenus Pharma aims to harness a specific, highly potent, and durable immune response against moving targets in cancer by claiming the representativity, the antigenicity, and the immunogenicity of its solution. The company was founded by Benoit Pinteur, Jacques Gardette. The CEO is Paul Bravetti. | Commercial Services |
